NO20042205L - Transdifferensiering av pankreatiske acinaerceller - Google Patents

Transdifferensiering av pankreatiske acinaerceller

Info

Publication number: NO20042205L
Authority: NO; Norway
Prior art keywords: transdifferentiation; acinar cells; pancreatic acinar; pancreatic; cells
Prior art date: 2002-01-11

Application number

NO20042205A

Other languages

English (en)

Norwegian (no)

Inventor

Lawrence Rosenberg

Original Assignee

Univ Mcgill

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-11

Filing date

2004-05-28

Publication date

2004-09-13

2004-05-28 Application filed by Univ Mcgill filed Critical Univ Mcgill

2004-09-13 Publication of NO20042205L publication Critical patent/NO20042205L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Biotechnology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Endocrinology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Marine Sciences & Fisheries (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicinal Preparation (AREA)

NO20042205A 2002-01-11 2004-05-28 Transdifferensiering av pankreatiske acinaerceller NO20042205L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US34689002P	2002-01-11	2002-01-11
PCT/CA2003/000013 WO2003057862A2 (en)	2002-01-11	2003-01-10	Transdifferentiation of pancreatic acinar cells

Publications (1)

Publication Number	Publication Date
NO20042205L true NO20042205L (no)	2004-09-13

Family

ID=23361448

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042205A NO20042205L (no)	2002-01-11	2004-05-28	Transdifferensiering av pankreatiske acinaerceller

Country Status (20)

Country	Link
US (1)	US7662768B2 (de)
EP (1)	EP1463801B1 (de)
JP (1)	JP2005514426A (de)
KR (1)	KR20040072680A (de)
CN (1)	CN1610693A (de)
AR (1)	AR038281A1 (de)
AT (1)	ATE404661T1 (de)
AU (1)	AU2003201553A1 (de)
BR (1)	BR0306656A (de)
CA (1)	CA2469052A1 (de)
DE (1)	DE60322831D1 (de)
IL (1)	IL162749A0 (de)
MA (1)	MA27413A1 (de)
MX (1)	MXPA04006385A (de)
NO (1)	NO20042205L (de)
PE (1)	PE20030744A1 (de)
PL (1)	PL371260A1 (de)
RU (1)	RU2004119417A (de)
TW (1)	TW200302228A (de)
WO (1)	WO2003057862A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060009516A1 (en) *	2002-10-24	2006-01-12	Mcgill University	Use of ingap for reversing diabetes
US20160039877A1 (en)	2013-03-15	2016-02-11	Shenzhen Hightide Biopharmaceutical, Ltd.	Compositions and methods of using islet neogenesis peptides and analogs thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0815129B1 (de)	1995-02-22	2011-01-05	Eastern Virginia Medical School of the Medical College of Hampton Roads	Ingap-protein und dessen beteiligung an der neogenese pankreatischer inselzellen
US5834590A (en)	1995-02-22	1998-11-10	Eastern Virginia Medical School Of The Medical College Of Hampton Roads	Ingap protein involved in pancreatic islet neogenesis
US20050053588A1 (en) *	2001-10-18	2005-03-10	Li Yin	Conversion of liver stem and progenitor cells to pancreatic functional cells

2003
- 2003-01-08 US US10/338,028 patent/US7662768B2/en not_active Expired - Fee Related
- 2003-01-09 PE PE2003000035A patent/PE20030744A1/es not_active Application Discontinuation
- 2003-01-09 AR ARP030100050A patent/AR038281A1/es unknown
- 2003-01-10 PL PL03371260A patent/PL371260A1/xx unknown
- 2003-01-10 CN CNA038018616A patent/CN1610693A/zh active Pending
- 2003-01-10 AU AU2003201553A patent/AU2003201553A1/en not_active Abandoned
- 2003-01-10 RU RU2004119417/14A patent/RU2004119417A/ru not_active Application Discontinuation
- 2003-01-10 BR BR0306656-8A patent/BR0306656A/pt not_active Application Discontinuation
- 2003-01-10 IL IL16274903A patent/IL162749A0/xx unknown
- 2003-01-10 CA CA002469052A patent/CA2469052A1/en not_active Abandoned
- 2003-01-10 EP EP03700250A patent/EP1463801B1/de not_active Expired - Lifetime
- 2003-01-10 JP JP2003558163A patent/JP2005514426A/ja active Pending
- 2003-01-10 TW TW092100552A patent/TW200302228A/zh unknown
- 2003-01-10 DE DE60322831T patent/DE60322831D1/de not_active Expired - Lifetime
- 2003-01-10 MX MXPA04006385A patent/MXPA04006385A/es not_active Application Discontinuation
- 2003-01-10 WO PCT/CA2003/000013 patent/WO2003057862A2/en not_active Ceased
- 2003-01-10 AT AT03700250T patent/ATE404661T1/de not_active IP Right Cessation
- 2003-01-10 KR KR10-2004-7010139A patent/KR20040072680A/ko not_active Withdrawn
2004
- 2004-05-28 NO NO20042205A patent/NO20042205L/no not_active Application Discontinuation
- 2004-06-28 MA MA27750A patent/MA27413A1/fr unknown

Also Published As

Publication number	Publication date
CN1610693A (zh)	2005-04-27
IL162749A0 (en)	2005-11-20
ATE404661T1 (de)	2008-08-15
DE60322831D1 (de)	2008-09-25
US7662768B2 (en)	2010-02-16
US20030203850A1 (en)	2003-10-30
AU2003201553A1 (en)	2003-07-24
PE20030744A1 (es)	2003-10-24
TW200302228A (en)	2003-08-01
CA2469052A1 (en)	2003-07-17
AR038281A1 (es)	2005-01-12
WO2003057862A3 (en)	2003-10-02
MA27413A1 (fr)	2005-07-01
PL371260A1 (en)	2005-06-13
EP1463801B1 (de)	2008-08-13
RU2004119417A (ru)	2005-02-27
BR0306656A (pt)	2004-10-05
EP1463801A2 (de)	2004-10-06
WO2003057862A2 (en)	2003-07-17
KR20040072680A (ko)	2004-08-18
MXPA04006385A (es)	2004-10-04
JP2005514426A (ja)	2005-05-19

Legal Events

Date	Code	Title	Description
2006-08-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK2508521T4 (da)	2022-10-03	Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf
FR15C0028I2 (fr)	2015-11-13	Fabrication de tiacumicine
DE60318920D1 (de)	2008-03-20	Induktion von Insulin-produzierende Zellen
DE60215683D1 (de)	2006-12-07	Uhrgehäuse
DK1546122T3 (da)	2008-03-03	Fremgangsmåde til fremstilling af valsartan
ITTO20030629A1 (it)	2004-02-18	Procedimento di realizzazione di collegamenti ad
NO20044916L (no)	2004-12-16	Preparater av sulfinylacetamid
DE602004026172D1 (de)	2010-05-06	Optischer detektor der enzymaktivierung
NO20044814L (no)	2004-01-07	Fremgangsmate for fremstilling av combretastaniner
DK1519928T3 (da)	2014-08-04	Fremgangsmåde til fremstilling af heterocykliske fluoralkenylsulfoner
IS6633A (is)	2004-05-23	Samsetningar af fínasteríð töflum
IS7833A (is)	2005-05-02	Efnasambönd með sameinaða heteróhringi
DK1532889T3 (da)	2007-05-21	Et sæt af juveler
DE50202991D1 (de)	2005-06-09	Hochtemperaturfestes Klebemittel
DK1511724T3 (da)	2014-06-16	Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1519936T3 (da)	2008-03-03	Fremgangsmåde til fremstilling af nevirapin
IL162749A0 (en)	2005-11-20	Transdifferentiation of pancreatic acinar cells
NO20044424L (no)	2004-10-19	Fremgangsmate for fremstilling av sertindol
UA6909S (uk)	2003-01-15	Комплект емблем
SE0103468D0 (sv)	2001-10-17	Stimulering av expansionen av progenitorceller från pankreas
DK1432452T3 (da)	2005-07-18	Inhibering af STAT-1
ATE556047T1 (de)	2012-05-15	Kristalline feste form der (2s-5z)-2-amino-7-
UY3316Q (es)	2002-07-31	Conjunto de panteones
FI20021940A0 (fi)	2002-10-31	Avoimen rakentamisen tehokkaampi toteuttaminen
FI20021941A0 (fi)	2002-10-31	Avoimen rakentamisen tehokkaampi toteuttaminen